Immediate Impact
3 from Science/Nature 52 standout
Citing Papers
Cancer therapy with antibodies
2024 Standout
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
Works of Bolette Bjerregaard being referenced
Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bolette Bjerregaard | 410 | 130 | 112 | 188 | 17 | 678 | |
| Jan Rydnert | 424 | 171 | 80 | 81 | 12 | 732 | |
| Eliana B Gómez | 426 | 70 | 157 | 104 | 25 | 765 | |
| J.R. Selden | 467 | 258 | 67 | 87 | 25 | 801 | |
| Jochen Bruch | 379 | 315 | 70 | 137 | 28 | 818 | |
| J Asakawa | 294 | 163 | 32 | 58 | 21 | 621 | |
| Ulla Bergholz | 398 | 190 | 80 | 113 | 16 | 684 | |
| Ann C. Burgess | 310 | 237 | 25 | 154 | 15 | 589 | |
| Eunike Velleuer | 541 | 220 | 46 | 155 | 27 | 826 | |
| B. Pym | 433 | 344 | 22 | 71 | 19 | 763 | |
| Susan Pfeifer | 408 | 194 | 44 | 71 | 21 | 651 |
All Works
Loading papers...